Economic evaluation of the effectiveness of therapy for purulent-catarrhal endometritis of cows with drugs of various pharmacological groups

Abstract

Ensuring the food independence of the population of Russia, reducing the consumption of imported food products is one of the priority tasks of our economy. Achieving this goal is impossible without a comprehensive solution of many important issues of conservation and development of animal husbandry, a significant increase in the productivity of various animal species. Prosperous development is hindered by obstetric and gynecological diseases, which cause significant economic damage due to a decrease in milk productivity and reproductive potential, and premature culling of cows. A predisposing factor in the development of the inflammatory process is the weakening of the body's resistance as a result of inadequate feeding, lack of exercise, keeping animals in rooms where the main parameters of the microclimate are violated. The use of the preparation containing silver nanoparticles argovit allows to reduce the duration of treatment in the absence of damage from the rejection of milk after therapy. The study was carried out in order to study the cost-effectiveness of the treatment of mastitis in cows with drugs of various pharmacological groups. Animals were divided into experimental and control groups according to the principle of analogues. During the treatment of purulent-catarrhal endometritis of cows, the experimental group was injected intrauterine with the drug argovit in the form of a 10% aqueous solution at a dose of 100 ml 1 time in 48 hours and uteroton intramuscularly 10 ml once every 48 hours. The control group was administered intrauterine metrobiotic 1 tablet 1 time in 24 hours and uteroton intramuscularly at a dose of 10 ml, once 1 time in 48 hours. The results of the research established a high economic efficiency of veterinary measures per 1 rub. costs in the treatment of purulent catarrhal endometritis of cows with Argovit (16.2 rub).